Simon Florian Preuss
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Simon Florian Preuss has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Orlando Guntinas-Lichius
Department of Otorhinolaryngology, Head and Neck Surgery, Jena University Hospital, Jena, Germany
10 shared publications Jens Peter Klussmann
University Hospital of Giessen
6 shared publicationsClaus Wittekindt
University of Jena
3 shared publicationsDirk Beutner
Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Cologne, Germany
3 shared publicationsRobert Semrau
University Hospital of Cologne
3 shared publicationsUta Drebber
University Hospital of Cologne
3 shared publications
Latest Publications
- 1 June 2014
- Published by Springer Nature
- Vol. 272 (7) , 1749-1754
Expression of podoplanin and prognosis in oropharyngeal cancer
It has been shown that podoplanin expression is associated with carcinoma of the aerodigestive tract. Recent studies indicate that podoplanin may serve as a prognostic biomarker in oral carcinoma. In order to provide evidence on the role of podoplanin in oropharyngeal squamous cell carcinoma, we evaluated the prognostic impact of podoplanin in these patients. We analyzed formalin-fixed tissue samples from 107 consecutive patients with oropharyngeal squamous cell carcinoma. HPV typing and immunohistochemical staining for both p16 and podoplanin were performed. Expression of podoplanin was seen in 38.3 % of all cases. We found no correlation of the podoplanin scores with either p16 expression or with HPV status. There was no significant correlation of podoplanin expression with the staging variables T, N, M, and tumor grading. Podoplanin expression did neither influence the 5-year overall survival nor the 5-year disease-free survival. Concluding, we could not find a prognostic role of podoplanin expression neither in the HPV-positive cases nor in the HPV-negative cases. It appears that podoplanin is not expressed as often in oropharyngeal cancer compared to oral cancer. We could not show any relation of lymph node metastases and podoplanin expression in this homogenous cohort of tumors.
- 1 June 2014
- Published by Springer Nature
- Vol. 272 (7) , 1749-1754
Expression of podoplanin and prognosis in oropharyngeal cancer
It has been shown that podoplanin expression is associated with carcinoma of the aerodigestive tract. Recent studies indicate that podoplanin may serve as a prognostic biomarker in oral carcinoma. In order to provide evidence on the role of podoplanin in oropharyngeal squamous cell carcinoma, we evaluated the prognostic impact of podoplanin in these patients. We analyzed formalin-fixed tissue samples from 107 consecutive patients with oropharyngeal squamous cell carcinoma. HPV typing and immunohistochemical staining for both p16 and podoplanin were performed. Expression of podoplanin was seen in 38.3 % of all cases. We found no correlation of the podoplanin scores with either p16 expression or with HPV status. There was no significant correlation of podoplanin expression with the staging variables T, N, M, and tumor grading. Podoplanin expression did neither influence the 5-year overall survival nor the 5-year disease-free survival. Concluding, we could not find a prognostic role of podoplanin expression neither in the HPV-positive cases nor in the HPV-negative cases. It appears that podoplanin is not expressed as often in oropharyngeal cancer compared to oral cancer. We could not show any relation of lymph node metastases and podoplanin expression in this homogenous cohort of tumors.
- 30 September 2011
- Published by Springer Nature in HNO
- Vol. 59 (10) , 1031-1038
Aktuelles zu HPV-induzierten Oropharynxkarzinomen
- 30 September 2011
- Published by Springer Nature in HNO
- Vol. 59 (10) , 1031-1038
Aktuelles zu HPV-induzierten Oropharynxkarzinomen
- 8 July 2010
- Published by Georg Thieme Verlag KG in Laryngo-Rhino-Otologie
- Vol. 89 (07) , 435-444
Ist die primäre Chirurgie bei fortgeschrittenen Kopf-Hals-Karzinomen noch aktuell?
Organerhaltende Therapiestrategien für Kopf-Hals-Karzinome haben in den letzten Jahren ihre Wirksamkeit in kontrollierten Studien bewiesen. Vor allem in den USA werden sie deshalb an vielen Kliniken der primär chirurgischen Therapie vorgezogen. Bestimmte Primärtumoren sprechen jedoch schlecht auf Radiochemotherapie an. Es hat sich weiterhin gezeigt, dass die Intensivierung der nicht chirurgischen Primärtherapien eine ausgeprägte Toxizität mit besorgniserregenden Mortalitätsraten aufweist. Viele Faktoren müssen bei der Wahl der Therapie berücksichtig werden. In dieser Übersichtsarbeit wird für die wichtigsten Primärtumorlokalisationen die aktuelle Literatur dargestellt und diskutiert. Organ preservation protocols for advanced head and neck carcinoma have proven to be successful in controlled clinical trials. This has led to an increase in the use of primary chemoradiation for these tumors. However, the intensification of nonoperative treatment protocols has been associated with a dramatic increase in acute treatment-related toxicity and mortality. In this paper, the role of primary surgical care is reviewed. Recent publications in the field and current treatment concepts are discussed.
- 8 July 2010
- Published by Georg Thieme Verlag KG in Laryngo-Rhino-Otologie
- Vol. 89 (07) , 435-444
Ist die primäre Chirurgie bei fortgeschrittenen Kopf-Hals-Karzinomen noch aktuell?
Organerhaltende Therapiestrategien für Kopf-Hals-Karzinome haben in den letzten Jahren ihre Wirksamkeit in kontrollierten Studien bewiesen. Vor allem in den USA werden sie deshalb an vielen Kliniken der primär chirurgischen Therapie vorgezogen. Bestimmte Primärtumoren sprechen jedoch schlecht auf Radiochemotherapie an. Es hat sich weiterhin gezeigt, dass die Intensivierung der nicht chirurgischen Primärtherapien eine ausgeprägte Toxizität mit besorgniserregenden Mortalitätsraten aufweist. Viele Faktoren müssen bei der Wahl der Therapie berücksichtig werden. In dieser Übersichtsarbeit wird für die wichtigsten Primärtumorlokalisationen die aktuelle Literatur dargestellt und diskutiert. Organ preservation protocols for advanced head and neck carcinoma have proven to be successful in controlled clinical trials. This has led to an increase in the use of primary chemoradiation for these tumors. However, the intensification of nonoperative treatment protocols has been associated with a dramatic increase in acute treatment-related toxicity and mortality. In this paper, the role of primary surgical care is reviewed. Recent publications in the field and current treatment concepts are discussed.
- 31 March 2009
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 35 (3) , 235-240
Transoral laser surgery for laryngeal cancer: Outcome, complications and prognostic factors in 275 patients
- 31 March 2009
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 35 (3) , 235-240
Transoral laser surgery for laryngeal cancer: Outcome, complications and prognostic factors in 275 patients
- 1 January 2009
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 129 (8) , 881-885
Second-look microlaryngoscopy to detect residual carcinoma in patients after laser surgery for T1 and T2 laryngeal cancer
Conclusions: The presented concept of second-look microlaryngoscopy in patients treated with transoral laser surgery (TLS) for early glottic carcinoma is promising and warrants further studies to evaluate its benefits. Objectives: Clear surgical margins at the primary site influence the course of the disease in patients with laryngeal carcinoma who undergo TLS. Several factors may lead to a reduced sensitivity in detecting tumor remnants at the time of the initial procedure. We therefore developed the concept of second-look microlaryngoscopies to enable a microscopic and histologic reassessment at the primary tumor site to exclude residual carcinoma. Patients and methods: Patients were scheduled for two second-look microlaryngoscopies under general anesthesia at 8–10 weeks and 16–20 weeks after the initial TLS procedure. We analyzed the histopathologic findings of biopsies taken in the second-look microlaryngoscopies and the survival parameters of 181 patients treated with TLS for early laryngeal carcinoma. Results: Carcinoma at the primary site was found in 5.1% of all patients within the first and in 11.5% of all patients within the second second-look microlaryngoscopy, although the preoperative indirect laryngoscopy was inconspicuous in most cases. The survival analysis showed a 5-year and 10-year disease-free survival of 96.3% and 92.7%, respectively. The disease-free survival was significantly decreased when carcinoma was found in the second-look microlaryngoscopy (p=0.004).
- 1 January 2009
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 129 (8) , 881-885
Second-look microlaryngoscopy to detect residual carcinoma in patients after laser surgery for T1 and T2 laryngeal cancer
Conclusions: The presented concept of second-look microlaryngoscopy in patients treated with transoral laser surgery (TLS) for early glottic carcinoma is promising and warrants further studies to evaluate its benefits. Objectives: Clear surgical margins at the primary site influence the course of the disease in patients with laryngeal carcinoma who undergo TLS. Several factors may lead to a reduced sensitivity in detecting tumor remnants at the time of the initial procedure. We therefore developed the concept of second-look microlaryngoscopies to enable a microscopic and histologic reassessment at the primary tumor site to exclude residual carcinoma. Patients and methods: Patients were scheduled for two second-look microlaryngoscopies under general anesthesia at 8–10 weeks and 16–20 weeks after the initial TLS procedure. We analyzed the histopathologic findings of biopsies taken in the second-look microlaryngoscopies and the survival parameters of 181 patients treated with TLS for early laryngeal carcinoma. Results: Carcinoma at the primary site was found in 5.1% of all patients within the first and in 11.5% of all patients within the second second-look microlaryngoscopy, although the preoperative indirect laryngoscopy was inconspicuous in most cases. The survival analysis showed a 5-year and 10-year disease-free survival of 96.3% and 92.7%, respectively. The disease-free survival was significantly decreased when carcinoma was found in the second-look microlaryngoscopy (p=0.004).
- 15 November 2008
- Published by Springer Nature
- Vol. 266 (2) , 309-310
Comments on the article by Redaelli de Zinis et al.: “Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature”
- 15 November 2008
- Published by Springer Nature
- Vol. 266 (2) , 309-310
Comments on the article by Redaelli de Zinis et al.: “Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature”
- Open Access
- 22 January 2008
- Published by Springer Nature in British Journal of Cancer
- Vol. 98 (3) , 627-632
Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer
The relationship between expression of the inhibitor of apoptosis protein survivin and the presence of high-risk human papillomavirus (HPV) in oropharyngeal squamous cell carcinoma (OSCC) remains unclear. This also accounts for its role as a predictor of survival. Therefore, we conducted a multicentre retrospective study on 106 consecutive oropharyngeal cancer patients. Human papillomavirus sequences were detected by nested PCR protocols. Survivin and p16 expression as a surrogate marker for HPV status were analysed by immunohistochemistry. Sequences of high-risk HPV were detected in 29% of cases. Prominent cytoplasmatic expression of survivin was found in 58% of cases and nuclear expression of survivin was found in 19% of the survivin-positive tumours. Nuclear expression of survivin was significantly correlated with HPV-negative tumours (P=0.023) and with a poor disease-free survival rate with an estimated 3-year disease-free survival probability of 35% for tumours with nuclear expression of survivin vs 78% for tumours with non-nuclear expression of survivin (hazard ratio=8.264; 95% confidence interval (95% CI)=2.510–27.210; PP=0.041 and hazard ratio=15.975; 95% CI=2.377–107.360; P=0.004, respectively). Our data show that nuclear accumulation of survivin correlates with HPV-independent carcinogenesis and is an independent predictor of poor survival in patients with OSCC.
- 22 January 2008
- Published by Springer Nature in British Journal of Cancer
- Vol. 98 (3) , 627-632
Open AccessNuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer
The relationship between expression of the inhibitor of apoptosis protein survivin and the presence of high-risk human papillomavirus (HPV) in oropharyngeal squamous cell carcinoma (OSCC) remains unclear. This also accounts for its role as a predictor of survival. Therefore, we conducted a multicentre retrospective study on 106 consecutive oropharyngeal cancer patients. Human papillomavirus sequences were detected by nested PCR protocols. Survivin and p16 expression as a surrogate marker for HPV status were analysed by immunohistochemistry. Sequences of high-risk HPV were detected in 29% of cases. Prominent cytoplasmatic expression of survivin was found in 58% of cases and nuclear expression of survivin was found in 19% of the survivin-positive tumours. Nuclear expression of survivin was significantly correlated with HPV-negative tumours (P=0.023) and with a poor disease-free survival rate with an estimated 3-year disease-free survival probability of 35% for tumours with nuclear expression of survivin vs 78% for tumours with non-nuclear expression of survivin (hazard ratio=8.264; 95% confidence interval (95% CI)=2.510–27.210; PP=0.041 and hazard ratio=15.975; 95% CI=2.377–107.360; P=0.004, respectively). Our data show that nuclear accumulation of survivin correlates with HPV-independent carcinogenesis and is an independent predictor of poor survival in patients with OSCC.
- 1 January 2008
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 128 (2) , 207-212
Mapping of Ki-67 protein distribution on whole organ serial sections of the larynx
Conclusions. Immunostaining of whole organ serial sections of the larynx is feasible and will allow analysis of cellular alterations in the undisturbed anatomical context of whole organ serial sections of the larynx. Objectives. Whole organ serial sections of the larynx have to date been used for conventional macroscopic evaluation of laryngeal tissues. The aim of this study was to establish a protocol for immunohistochemistry of whole organ sections of the larynx. Materials and methods. Five laryngectomy specimens were obtained during surgery for advanced laryngeal carcinoma. Using a novel method for paraffin embedding, we chose the proliferation marker Ki-67 antigen as a model target for immunoreactivity on serial sections. Results. We were able to produce whole organ serial sections that could then be immunostained for Ki-67. A complete mapping of proliferating cells throughout the tumour, at the tumour front and in skip lesions was subsequently obtained.
- 1 January 2008
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 128 (2) , 207-212
Mapping of Ki-67 protein distribution on whole organ serial sections of the larynx
Conclusions. Immunostaining of whole organ serial sections of the larynx is feasible and will allow analysis of cellular alterations in the undisturbed anatomical context of whole organ serial sections of the larynx. Objectives. Whole organ serial sections of the larynx have to date been used for conventional macroscopic evaluation of laryngeal tissues. The aim of this study was to establish a protocol for immunohistochemistry of whole organ sections of the larynx. Materials and methods. Five laryngectomy specimens were obtained during surgery for advanced laryngeal carcinoma. Using a novel method for paraffin embedding, we chose the proliferation marker Ki-67 antigen as a model target for immunoreactivity on serial sections. Results. We were able to produce whole organ serial sections that could then be immunostained for Ki-67. A complete mapping of proliferating cells throughout the tumour, at the tumour front and in skip lesions was subsequently obtained.
- 1 September 2007
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 28 (6) , 774-777
Results of a European Survey on Current Controversies in Otology
Objective: Various topics in otology cause controversy among otologists internationally. The resulting variety of diagnostic and surgical concepts reflects differences between surgical schools and the lack of structured studies in the field. Interventions: During the "Third Instructional Workshop of the European Academy of Otology and Neuro-Otology," we interviewed 100 invited instructors using a written questionnaire on 13 controversial topics in otology. Results: The analyses of the survey showed a variety of different approaches in most otologic topics. Conclusion: A further exchange of experiences and discussions in expert panels such as the Instructional Workshop of the European Academy of Otology and Neuro-Otology may help standardize concepts in otology for a safe, efficient, and cost-effective standard of care in otology.
- 1 September 2007
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 28 (6) , 774-777
Results of a European Survey on Current Controversies in Otology
Objective: Various topics in otology cause controversy among otologists internationally. The resulting variety of diagnostic and surgical concepts reflects differences between surgical schools and the lack of structured studies in the field. Interventions: During the "Third Instructional Workshop of the European Academy of Otology and Neuro-Otology," we interviewed 100 invited instructors using a written questionnaire on 13 controversial topics in otology. Results: The analyses of the survey showed a variety of different approaches in most otologic topics. Conclusion: A further exchange of experiences and discussions in expert panels such as the Instructional Workshop of the European Academy of Otology and Neuro-Otology may help standardize concepts in otology for a safe, efficient, and cost-effective standard of care in otology.
- 1 May 2007
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 65 (5) , 953-957
Submandibular Gland Excision: 15 Years of Experience
- 1 May 2007
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 65 (5) , 953-957
Submandibular Gland Excision: 15 Years of Experience